StonvexLoading…
StonvexStonvexStonvexCore line items from NRDY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $178.99M | $190.23M | $193.40M | $162.66M |
Operating Income | $-61.86M | $-70.11M | $-57.57M | $-90.81M |
Net Income | $-39.92M | $-42.59M | $-40.17M | $-35.40M |
EPS (Diluted) | $-0.33 | $-0.38 | $-0.41 | $-0.41 |
Total Assets | $76.17M | $92.51M | $124.74M | $132.69M |
Total Liabilities | $47.23M | $31.39M | $39.14M | $51.64M |
Cash & Equivalents | $47.90M | $52.54M | $74.82M | $90.72M |
Free Cash Flow OCF − CapEx | $-24.22M | $-22.47M | $-14.45M | $-53.32M |
Shares Outstanding | 120.83M | 111.69M | 97.16M | 85.87M |